Bristol-Myers Squibb (BMY) Q4 2022 Earnings Call Transcript

BMY earnings call for the period ending December 31, 2022.

Related Keywords

Puerto Rico ,Japan ,Netherlands ,Canada ,Massachusetts ,United States ,Andrew Baum ,Chris Boerner ,Chris Shibutani ,Terence Flynn Morgan Stanley ,Olivia Brayer Cantor Fitzgerald ,Terence Flynn ,Giovanni Caforio ,Andrew Baum Citi ,Geoff Meacham ,Carter Gould Barclays ,Steve Scala Cowen ,Seamus Fernandez Guggenheim ,David Elkins ,Bristol Myers Squibb ,Matt Phipps ,Robert Plenge ,Mohit Bansal ,William Blair ,Robyn Karnauskas ,Tim Anderson ,Evan Seigerman ,Carter Gould ,Samit Hirawat ,Matt Phipps William Blair ,Olivia Brayer ,Steve Scala ,America Merrill Lynch ,Chris Schott Jpmorgan ,Seamus Fernandez ,Robyn Karnauskas Truist ,Chris Shibutani Goldman Sachs ,Chris Schott ,Rupert Vessey ,Colin Bristow ,Morgan Stanley ,Tim Anderson Wolfe Research Analyst ,Head Of Global Drug Development ,Goldman Sachs ,Geoff Meacham Bank ,Pfizer ,Cantor Fitzgerald ,Wolfe Research ,Company Analyst ,Barclays ,Wells Fargo ,Stim Power ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,Medicare Coverage Gap ,Turning Point ,Turning Point Therapeutics ,Medical Officer ,Global Drug ,Fargo Securities ,Maybei Ll ,Chief Commercialization ,Guggenheim Partners ,Chief Medical Officer ,Wells Fargo Securities ,